EpiBone, Inc. Receives FDA Clearance to Commence its First-In-...
NEW YORK, May 22, 2019 /PRNewswire-AsiaNet/ -- -- Potential breakthrough technology for stem-cell based bone replacementEpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinic...
Authors: LATEST ASIANET NEWS RELEASES